Internal Medicine, Gastroenterology · Valhalla, NY
NPI
1528170362
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
Nymc-Munger Pavilion, Suite 206
Valhalla, NY, 10595
Phone (914) 493-7337
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
589 services
Medicare patients, 2024
246
Average age 70
Drug cost, 2024
$747K
1,476 prescriptions
Company payments, 2025
$406
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brad M Dworkin was code 99214 (office e&m - established), 232 times for 142 patients. In total Brad M Dworkin billed 589 services in 31 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-07-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 232 | 142 | $100.06 | $23K |
| 43239 Upper GI Endoscopy | Facility | 68 | 66 | $78.09 | $5,310 |
| 99215 Office E&M - Established | Office | 51 | 34 | $156.15 | $7,963 |
| 45380 Lower GI Endoscopy - Other | Facility | 30 | 30 | $140.73 | $4,222 |
| 99204 Office E&M - New | Office | 22 | 22 | $140.81 | $3,098 |
| 45378 Lower GI Endoscopy - Other | Facility | 21 | 21 | $150.83 | $3,168 |
| 99213 Office E&M - Established | Office | 17 | 17 | $76.58 | $1,302 |
| 45385 Colonoscopy - Lesion Removal | Facility | 17 | 17 | $231.37 | $3,933 |
| 99203 Office E&M - New | Office | 16 | 16 | $94.12 | $1,506 |
| 91010 Test - Miscellaneous | Office | 15 | 15 | $200.46 | $3,007 |
| 91037 Test - Miscellaneous | Office | 14 | 14 | $152.94 | $2,141 |
| 99205 Office E&M - New | Office | 12 | 12 | $181.12 | $2,173 |
By year: 2022 $65K for 439 services; 2023 $91K for 548 services; 2024 $76K for 589 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brad M Dworkin prescribed most often to Medicare patients was Famotidine, with 214 prescriptions and refills. In total Brad M Dworkin wrote 1,476 Medicare prescriptions that cost $747K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 214 | 447 | 65 | $4,277 |
| Pantoprazole Sodium Generic | 208 | 464 | 74 | $3,037 |
| Linzess Linaclotide | 108 | 148 | 37 | $80K |
| Omeprazole Generic | 99 | 249 | 39 | $1,505 |
| Diphenhydramine Hcl Generic | 75 | 75 | Under 11 | $3,234 |
| Ondansetron Odt Ondansetron | 66 | 88 | 33 | $4,805 |
| Sucralfate Generic | 54 | 66 | 21 | $7,268 |
| Motegrity Prucalopride Succinate | 45 | 67 | 17 | $35K |
| Zenpep Lipase/Protease/Amylase | 44 | 46 | Under 11 | $92K |
| Ondansetron Hcl Ondansetron Hcl/Pf | 37 | 37 | Under 11 | $878 |
| Lactated Ringers Ringer's Solution,lactated | 27 | 27 | Under 11 | $713 |
| Famotidine Famotidine/Pf | 26 | 26 | Under 11 | $113 |
| Xifaxan Rifaximin | 23 | 25 | 15 | $59K |
| Mesalamine Generic | 21 | 35 | Under 11 | $3,405 |
| Dicyclomine Hcl Generic | 20 | 20 | Under 11 | $376 |
Brand drugs: - claims; generic drugs: 1,083 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brad M Dworkin $406 ($406 in general payments such as food, travel and fees) from 11 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $68.49.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $68.49 |
| Abbvie Inc. ABBV | 3 | $65.89 |
| Ardelyx, Inc. ARDX | 3 | $62.2 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $41.04 |
| Madrigal Pharmaceuticals MDGL | 2 | $37.03 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $31.68 |
| QOL Medical, LLC | 1 | $30.71 |
| Aimmune Therapeutics, Inc. | 1 | $21.1 |
| Janssen Biotech, Inc. JNJ | 1 | $17.18 |
| Fujifilm Healthcare Americas Corporation | 1 | $16.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.